6IB.STU Innovent Biologics Inc

- EUR
Market cap
-
P/E
114.5x
P/B
6.55x
ROE
4.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6IB.STU undervalued?

Graham number

The Graham number of Innovent Biologics Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Innovent Biologics Inc fundamental analysis

No fundamental analysis for Innovent Biologics Inc yet.

Innovent Biologics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.